New knee injection trial aims to ease arthritis pain and stiffness
NCT ID NCT07404891
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an investigational drug called ALT001 for people with knee osteoarthritis. The goal is to see if it can reduce pain, improve movement, and boost quality of life. About 30 adults aged 50 to 75 will receive injections into the knee every two weeks for 12 weeks. The trial will also monitor side effects closely.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for KNEE OSTEOARTHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
RECRUITINGWuhan, Hubei, 430022, China
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AI reads knee ultrasounds to predict injection success
- Bowlegs and knee surgery: does preoperative alignment change pain outcomes?
- Ozone therapy put to the test: could it harm your eyes?
- Robot-Assisted knee surgery tests custom alignment for Longer-Lasting implants
- New supplement blend may rival glucosamine for knee arthritis relief
- Mindful walking may ease knee pain without pills